- Report
- January 2022
- 40 Pages
Germany
From €1432EUR$1,500USD£1,199GBP
- Report
- January 2022
- 40 Pages
Ireland
From €1432EUR$1,500USD£1,199GBP
- Report
- January 2022
- 40 Pages
Japan
From €1432EUR$1,500USD£1,199GBP
- Report
- January 2022
- 40 Pages
Russia
From €1432EUR$1,500USD£1,199GBP
- Report
- January 2022
- 40 Pages
South Korea
From €1432EUR$1,500USD£1,199GBP
- Report
- January 2022
- 40 Pages
United States
From €1432EUR$1,500USD£1,199GBP
- Report
- January 2022
- 40 Pages
Vietnam
From €1432EUR$1,500USD£1,199GBP
- Report
- January 2022
- 40 Pages
Brazil
From €1432EUR$1,500USD£1,199GBP
- Report
- January 2022
- 40 Pages
China
From €1432EUR$1,500USD£1,199GBP
- Report
- March 2024
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Report
- March 2024
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Report
- March 2024
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Report
- March 2024
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Report
- December 2019
- 222 Pages
Global
From €5125EUR$5,370USD£4,294GBP
- Book
- March 2015
- 512 Pages
- Book
- October 2010
- 408 Pages
- Book
- October 2019
China

The Vasodilator market is a segment of the Medical Devices industry that focuses on the development and sale of products used to widen blood vessels. These products are used to treat a variety of conditions, including hypertension, coronary artery disease, and peripheral vascular disease. Vasodilators are typically administered through injection, infusion, or inhalation, and can be used to reduce blood pressure, improve blood flow, and reduce the risk of stroke and heart attack.
The Vasodilator market is highly competitive, with a number of large and small companies offering a variety of products. Major players in the market include Pfizer, Merck, Novartis, and Sanofi, while smaller companies such as Bausch Health, Mylan, and Teva Pharmaceuticals also offer products. Additionally, many generic drug manufacturers produce generic versions of popular vasodilators. Show Less Read more